(Q34941213)

5 August 2017

1 reference

title

Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion (English)

1 reference

5 August 2017

0 references

1 reference

Nicola Conran

1

1 reference

5 August 2017

Carla F Franco-Penteado

series ordinal

2

1 reference

5 August 2017

Fernando F Costa

series ordinal

3

1 reference

5 August 2017

publication date

1 January 2009

1 reference

5 August 2017

1 reference

5 August 2017

volume

33

1 reference

5 August 2017

issue

1

1 reference

5 August 2017

page(s)

1-16

1 reference

Management of sickle cell disease.

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Pathophysiology and therapy for haemoglobinopathies. Part I: sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Delay time of hemoglobin S polymerization prevents most cells from sickling in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Sickle cell vaso-occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Sickle cell disease: old discoveries, new concepts, and future promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Pathophysiology and treatment of stroke in sickle-cell disease: present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Serum levels of angiogenic factors indicate a pro-angiogenic state in adults with sickle cell disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Role of Rap1 in promoting sickle red blood cell adhesion to laminin via BCAM/LU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Epinephrine acts through erythroid signaling pathways to activate sickle cell adhesion to endothelium via LW-alphavbeta3 interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

beta(2)-Adrenergic receptor and adenylate cyclase gene polymorphisms affect sickle red cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Phosphatidylserine externalization in sickle red blood cells: associations with cell age, density, and hemoglobin F.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Sickle cell adhesion depends on hemodynamics and endothelial activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Prediction of adverse outcomes in children with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Effect of cytokines and chemokines on sickle neutrophil adhesion to fibronectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Hydroxyurea corrects the dysregulated L-selectin expression and increased H(2)O(2) production of polymorphonuclear neutrophils from patients with sickle cell anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso-occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Fibronectin bridges monocytes and reticulocytes via integrin alpha4beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Sickle cell vaso-occlusion: multistep and multicellular paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Increased adhesive properties of eosinophils in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Role for cAMP-protein kinase A signalling in augmented neutrophil adhesion and chemotaxis in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Hypoxia, leukocytes, and the pulmonary circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Leg ulceration in sickle cell disease: medieval medicine in a modern world

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

The causes of skin damage and leg ulceration in chronic venous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Platelet activation in patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Cellular signaling with nitric oxide and cyclic GMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Nitric oxide has a role in regulating VLA-4-integrin expression on the human neutrophil cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Nitric oxide regulates human eosinophil adhesion mechanisms in vitro by changing integrin expression and activity on the eosinophil cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Sickle cell disease and nitric oxide: a paradigm shift?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

New strategies for the treatment of pulmonary hypertension in sickle cell disease : the rationale for arginine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Sickle cell disease: role of reactive oxygen and nitrogen metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Spontaneous oxygen radical generation by sickle erythrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Effect of hydroxyurea on G gamma chain fetal hemoglobin synthesis by sickle-cell disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Induction of fetal hemoglobin in the treatment of sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Catalase-mediated nitric oxide formation from hydroxyurea

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Nitric oxide production from hydroxyurea

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Hydroxyurea and arginine therapy: impact on nitric oxide production in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Sodium nitrite promotes regional blood flow in patients with sickle cell disease: a phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Increased adhesive properties of neutrophils in sickle cell disease may be reversed by pharmacological nitric oxide donation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

High expression of the cGMP-specific phosphodiesterase, PDE9A, in sickle cell disease (SCD) and the effects of its inhibition in erythroid cells and SCD neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Small-molecule cyclic alpha V beta 3 antagonists inhibit sickle red cell adhesion to vascular endothelium and vasoocclusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Rationale for intracoronary administration of abciximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Modulation of endothelial cell activation in sickle cell disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Polynitroxyl albumin inhibits inflammation and vasoocclusion in transgenic sickle mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

Treatment with NS3623, a novel Cl-conductance blocker, ameliorates erythrocyte dehydration in transgenic SAD mice: a possible new therapeutic approach for sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03630260802625709

10.1080/03630260802625709

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference